Dorsky D I, Wells M, Harrington R D
Division of Infectious Diseases, University of Connecticut Health Center, Farmington, USA.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):308-13. doi: 10.1097/00042560-199612010-00002.
Several systems for the detection of HIV-1 have been described in which HIV-1-susceptible cells contain a reporter gene (chloramphenicol acetyltransferase, beta-galactosidase, or alkaline phosphatase) under the control of the HIV-1 long terminal repeat (LTR). Upon infection by HIV-1, the expression of the viral tat product increases transcription from the HIV-1 LTR promoter, leading to high-level expression of the reporter gene product. Previously described reporter systems require processing of the cells by lysis, fixation, or other steps following infection to detect the reporter gene product. In the present study, the Aequorea green fluorescent protein S65T variant (GFP-S65T) was used in a reporter system for detecting HIV-1. HeLa-CD4 cells transfected with the plasmid pRH1, which encodes GFP-S65T under the control of the HIV-1 LTR promoter, and either co-transfected with a plasmid encoding the HIV-1 tat product or superinfected with HIV-1, expressed high levels of GFP-S65T, which was readily detected by fluorescence microscopy and fluorescence-activated cell-sorting analysis. The advantages of this system include its simplicity, sensitivity, and ability to detect and sort live HIV-1-infected cells using readily available instruments. The construction of cell lines stably transfected with pRH1 will provide a tool for titering HIV-1 and sorting HIV-1-infected cells.
已经描述了几种用于检测HIV-1的系统,其中HIV-1易感细胞含有在HIV-1长末端重复序列(LTR)控制下的报告基因(氯霉素乙酰转移酶、β-半乳糖苷酶或碱性磷酸酶)。在被HIV-1感染后,病毒tat产物的表达增加了HIV-1 LTR启动子的转录,导致报告基因产物的高水平表达。先前描述的报告系统需要在感染后通过裂解、固定或其他步骤处理细胞以检测报告基因产物。在本研究中,海肾绿色荧光蛋白S65T变体(GFP-S65T)被用于一个检测HIV-1的报告系统。用质粒pRH1转染的HeLa-CD4细胞,该质粒在HIV-1 LTR启动子的控制下编码GFP-S65T,并且要么与编码HIV-1 tat产物的质粒共转染,要么被HIV-1超感染,表达高水平的GFP-S65T,通过荧光显微镜和荧光激活细胞分选分析很容易检测到。该系统的优点包括其简单性、敏感性以及使用现成仪器检测和分选活的HIV-1感染细胞的能力。用pRH1稳定转染的细胞系的构建将为测定HIV-1滴度和分选HIV-1感染细胞提供一种工具。